DigestRedComo funciona
Red
/
Empresas
Ot
No verificado

Otsuka Pharmaceutical Co., Ltd.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaSaludSanidad

17 Comunicados de prensa

Ver todos los comunicados de prensa
12/06/2026
Mercado de valores
Biotecnología
Sanidad
Psiquiatría
Salud
Farmacéutica
Otsuka Completes Acquisition of Transcend Therapeutics to Advance Next-Generation Neuropsychiatric Treatments
Fuente
Otsuka Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
04/06/2026
Otsuka Presents Positive Interim Phase 3 VISIONARY eGFR Data Showing VOYXACT® (sibeprenlimab-szsi) Preserved Kidney Function Over 12 Months in IgA Nephropathy (IgAN)
Fuente
Otsuka Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
28/05/2026
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Eventos
Industria
Otsuka Presents New Phase 3 Post Hoc Analyses of Centanafadine Highlighting Improvement in Executive Function and Emotional Dysregulation in Adults with ADHD at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
Fuente
Otsuka Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
25/03/2026
Eventos
Industria
Sanidad
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Otsuka Showcases New Efficacy and Safety Data of VOYXACT® (sibeprenlimab-szsi) in Patients with IgA Nephropathy (IgAN) at the 2026 ISN World Congress of Nephrology Highlighting the Impact of APRIL Inhibition
Fuente
Otsuka Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
12/03/2026
Eventos
Industria
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Otsuka Unveils New Repinatrabit Open-Label Extension Data in Phenylketonuria (PKU) Signaling Efficacy in Adolescents at the 2026 American College of Medical Genetics and Genomics (ACMG) Meeting
Fuente
Otsuka Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
27/01/2026
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Higiene alimentaria
Medicina - Varios
Industria
Otsuka Announces FDA Acceptance and Priority Review of New Drug Application for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults
Fuente
Otsuka Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
25/11/2025
Industria
Salud
Higiene alimentaria
Sanidad
Medicina - Varios
Ciencia
Farmacéutica
Otsuka Pharmaceutical Submits New Drug Application to U.S. FDA for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults
Fuente
Otsuka Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
06/06/2025
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Sanidad
Otsuka Sibeprenlimab Phase 3 Data Show a Statistically Significant and Clinically Meaningful Proteinuria Reduction for the Treatment of Immunoglobulin A Nephropathy (IgAN)
Fuente
Otsuka Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
27/05/2025
Sanidad
Web y redes sociales
Mundo del espectáculo
Cine
Farmacéutica
Psiquiatría
Sociedad/Prensa del corazón
Programas radio
Biotecnología
Asistencia a la infancia
Salud
Industria
Análisis de Mercados
Eventos
PBS and WETA Caregiving Documentary by Executive Producer Bradley Cooper Now Available to Stream
Fuente
Otsuka Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
27/05/2025
Higiene alimentaria
Salud
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Industria
Otsuka Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
Fuente
Otsuka Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0